Cytosine Arabinoside in Addition to VCAA-based Protocols for the Treatment of Canine Lymphoma With Bone Marrow Involvement: Does It Make the Difference?

Veterinary and Comparative Oncology - United Kingdom
doi 10.1111/j.1476-5829.2007.00141.x
Full Text
Abstract

Available in full text

Categories
Veterinary
Date
Authors
Publisher

Wiley

Related search

Evaluating the Use of Cytosine Arabinoside for Treatment for Recurrent Canine Steroid-Responsive Meningitis-Arteritis

Veterinary Record
MedicineVeterinary
2020English

What Difference Does It Make?

English

DNA Thioaptamer With Homing Specificity to Lymphoma Bone Marrow Involvement

English

Value of Detecting Bone Marrow Involvement in Hodgkin Lymphoma

British Journal of Haematology
Hematology
2019English

Covering the Uninsured Through TennCare: Does It Make a Difference?

Health Affairs
MedicineHealth Policy
2001English

Glycaemic Variability: Does It Make a Difference in Prediabetes?

Endocrine Abstracts
2013English

WHERE You Get It...DOES Make a Difference

Chemical and Engineering News
Chemical Engineering
1951English

WHERE You Get It... DOES Make a Difference

Chemical and Engineering News
Chemical Engineering
1951English

To Accept or Decline Academic Remediation: What Difference Does It Make?

Medical Teacher
MedicineEducation
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy